IQGAP3 May Serve as a Promising Biomarker in Clear Cell Renal Cell Carcinoma

被引：3

作者：

Meng, Quan ^{[1
]}

Li, Can-Xuan ^{[2
]}

Long, Dan ^{[3
]}

Lin, Xiaobin ^{[4
]}

机构：

[1] Shenzhen Tradit Chinese Med Hosp, Dept Clin Lab, Shenzhen, Guangdong, Peoples R China

[2] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Shenshan Cent Hosp, Dept Urol, Shanwei, Guangdong, Peoples R China

[3] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Shenshan Cent Hosp, Resp Med, Shanwei, Guangdong, Peoples R China

[4] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Dept Breast Surg & Gen Surg, Guangzhou, Guangdong, Peoples R China

来源：

INTERNATIONAL JOURNAL OF GENERAL MEDICINE | 2021年 / 14卷

关键词：

IQGAP3; clear cell renal cell carcinoma; prognosis; CANCER; DNA; EXPRESSION;

D O I：

10.2147/IJGM.S316280

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Aim: The study was designed to mine the expression and roles of IQGAP3 in clear cell renal cell carcinoma (ccRCC). Methods: Expression profiles and clinical information were obtained from the Cancer Genome Atlas (TCGA) to estimate IQGAP3 expression in ccRCC, its relationship with patients' clinicopathological variables and prognosis, and the potential biological mechanisms. Results: IQGAP3 was highly expressed in ccRCC and indicated advanced clinical outcome and poor prognosis. IQGAP3 affected the progression of ccRCC through several cancer related pathways. IQGAP3 might play a vital role in the ccRCC tumor microenvironment. Conclusion: IQGAP3 could serve as a promising prognostic biomarker and therapeutic target.

引用

页码：3469 / 3484

页数：16

共 50 条

[41] Clear Cell Renal Cell Carcinoma
Erickson, Lori A.
MAYO CLINIC PROCEEDINGS, 2018, 93 (06) : 813 - 814
[42] Clear cell renal cell carcinoma
Grignon, DJ
Che, MX
CLINICS IN LABORATORY MEDICINE, 2005, 25 (02) : 305 - +
[43] Identification and validation of TGFBI as a promising prognosis marker of clear cell renal cell carcinoma
Lebdai, Souhil
Verhoest, Gregory
Parikh, Hemang
Jacquet, Solene Florence
Bensalah, Karim
Chautard, Denis
Leclercq, Nathalie Rioux
Azzouzi, Abdel Rahmene
Bigot, Pierre
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (02) : 69.e11 - 69.e18
[44] TIGIT may Serve as a Potential Target for the Immunotherapy of Renal Cell Carcinoma
Hong, Xin
Yu, Chengfan
Bi, Jianlong
Liu, Qing
Wang, Qiang
ADVANCED BIOLOGY, 2024, 8 (01):
[45] Clear cell thyroid carcinoma in a patient with clear cell renal cell carcinoma: Not as clear as it seems
Rosell, Alejandra
Munoz de Nova, Jose L.
Lahera, Marcos
Mingo, Alberto
Jimenez-Heffernan, Jose A.
CYTOPATHOLOGY, 2021, 32 (04) : 541 - 544
[46] Vascular architectural patterns in clear cell renal cell carcinoma and clear cell papillary renal cell carcinoma
Canete-Portillo, Sofia
Pena, Maria del Carmen Rodriguez
Wang, Dezhi
Sanchez, Diego F.
Netto, George J.
Magi-Galluzzi, Cristina
VIRCHOWS ARCHIV, 2021, 479 (06) : 1187 - 1196
[47] Vascular architectural patterns in clear cell renal cell carcinoma and clear cell papillary renal cell carcinoma
Sofia Canete-Portillo
Maria del Carmen Rodriguez Pena
Dezhi Wang
Diego F. Sanchez
George J. Netto
Cristina Magi-Galluzzi
Virchows Archiv, 2021, 479 : 1187 - 1196
[48] Homologous recombination deficiency serves as a prognostic biomarker in clear cell renal cell carcinoma
He, Liping
Gao, Feng
Zhu, Jingyu
Xu, Qiaoping
Yu, Qiqi
Yang, Mei
Huang, Yasheng
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 26 (03)
[49] Identification of ALDOB as a novel prognostic biomarker in kidney clear cell renal cell carcinoma
Li, Xiao-yang
Xu, You-yao
Wu, Sen-yan
Zeng, Xi -xi
Zhou, Yan
Cheng, Guo-bin
HELIYON, 2024, 10 (08)
[50] LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma
Chunxiu Yang
Jingjing Pang
Jian Xu
He Pan
Yueying Li
Huainian Zhang
Huan Liu
Shu-Yuan Xiao
Cancer Cell International, 21

← 1 2 3 4 5 →